期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy 被引量:21
1
作者 Hao Peng Lei Chen +11 位作者 Ling-Long Tang Wen-Fei Li Yan-Ping Mao Rui Guo Yuan Zhang Li-Zhi Liu Li Tian Xu Zhang Xiao-Ping Lin Ying Guo Ying Sun Jun Ma 《Chinese Journal of Cancer》 SCIE CAS CSCD 2017年第12期757-766,共10页
Background: Little is known about the nature of metaistasis to small cervical lymph nodes(SCLNS) in the patients with nasopharyngeal carcinoma(NPC)examined by using 18-fluoro-2-deoxy-glucose(^(18)F-FDG) positron emiss... Background: Little is known about the nature of metaistasis to small cervical lymph nodes(SCLNS) in the patients with nasopharyngeal carcinoma(NPC)examined by using 18-fluoro-2-deoxy-glucose(^(18)F-FDG) positron emission tomography/computed tomography(PET/CT).The present study aimed to evaluate the diagnostic values of PET/CT in identifying metastasis in SCLNs in NPC patients.Methods: Magnetic resonance images(MRI) and PET/CT scans for 470 patients with newly diagnosed, non-distant metastatic NPC were analyzed. Metastatic rates of SCLNs were defined by the positive number of SCLNs on PET/CT scans and total number of SCLNs on MRI scans. Receiver operating characteristic curve was applied to compare PET/CT-determined stage with MRI-determined stage.Results: In total, 2082 SCLNs were identified, with 808(38.8%) ≥ 5 and < 6 mm in diameter(group A), 526(25.3%)≥ 6 and < 7 mm in diameter(group B),374(18.0%)≥ 7 and < 8 mm in diameter(group C), 237(11.4%) ≥8 and<9 mm in diameter(group D),and 137(6.5%) ≥ 9 and <10 mm in diameter(group E).The overall metastatic rates examined by using PET/CT for groups A, B,C,D, and E were 3.5%, 8.0%, 31.3%, 60.0%, and 83.9%, respectively(P< 0.001). In level IV/Vb, the metastatic rate for nodes ≥ 8 mm was 84.6%. PET/CT examination resulted in modification of N category and overall stage for 135(28.7%) and 46(9.8%) patients, respectively. The areas under curve of MRIdetermined and PET/CT-determined overall stage were 0.659 and 0.704 for predicting overall survival, 0.661 and 0.711 for predicting distant metastasis-free survival, and 0.636 and 0.663 for predicting disease-free survival.Conclusions: PET/CT was more effective than MRI in identifying metastatic SCLNs, and the radiologic diagnostic criteria for metastatic lymph nodes in level IV/Vb should be re-defined. 展开更多
关键词 NASOPHARYNGEAL carcinoma 18-fluoro-2-deoxy-glucose positron emission TOMOGRAPHY with computed TOMOGRAPHY (18f-PET/CT) Magnetic resonance image INTENSITY-modulATED radiotherapy SMALL cervical LYMPH nodes
暂未订购
HD-YOLO:复杂场景下安全帽佩戴检测算法 被引量:2
2
作者 邱云飞 腰瑞琳 +1 位作者 金海波 张嘉宁 《安全与环境学报》 北大核心 2025年第1期165-174,共10页
针对目标密集、有遮挡的复杂施工场景下安全帽佩戴检测存在漏检、误检的问题,提出了一种基于YOLOv8的HD-YOLO安全帽佩戴检测算法。首先,设计了GRC-C2f结构,使用多分支结构捕获多尺度特征,兼顾训练阶段的特征提取能力和推理阶段的计算效... 针对目标密集、有遮挡的复杂施工场景下安全帽佩戴检测存在漏检、误检的问题,提出了一种基于YOLOv8的HD-YOLO安全帽佩戴检测算法。首先,设计了GRC-C2f结构,使用多分支结构捕获多尺度特征,兼顾训练阶段的特征提取能力和推理阶段的计算效率。其次,设计了DSASF颈部结构,结合动态上采样和多尺度特征融合,精准识别和定位图像中的小目标,以提高检测性能。然后,引入Focal Modulation模块替换原有的快速空间金字塔池化(Spatial Pyramid Pooling-Fast,SPPF)结构模块,捕捉图像中的长距离依赖和上下文信息,聚焦于复杂背景中的目标。最后,采用空间增强注意力模块(Spatially Enhanced Attention Module,SEAM)解决小目标遮挡问题。试验结果表明,HD-YOLO算法在同一数据集上平均精度均值为81.8%,相比原始YOLOv8算法提高了5.0百分点。设计的HD-YOLO算法有效提高了复杂场景中佩戴安全帽的检测精度。 展开更多
关键词 安全社会工程 安全帽检测 YOLOv8算法 grc-c2f模块 DSASf颈部结构 focal modulation模块 空间增强注意力模块
原文传递
Noether子模的Extending性质
3
作者 汪小琳 《纯粹数学与应用数学》 CSCD 2003年第4期351-353,共3页
将f-Extending模的结果推广到二型Noetherian-Extending模,得到了二型Noetherian-Extending模的一些性质.
关键词 f-Extending模 二型Noetherian—Extending模
在线阅读 下载PDF
Fluorine-induced dual defects in NiP_(2) anode with robust sodium storage performance
4
作者 Liang Wu Lifeng Wang +6 位作者 Xiaolong Cheng Mingze Ma Ying Wu Xiaojun Wu Hengpan Yang Yan Yu Chuanxin He 《Nano Research》 SCIE EI CSCD 2022年第3期2147-2156,共10页
Metal phosphides have shown great application potential as anode for sodium-ion batteries(NIBs)owing to high theoretical capacity,suitable operation voltage and abundant resource.Unfortunately,the application of NiP_(... Metal phosphides have shown great application potential as anode for sodium-ion batteries(NIBs)owing to high theoretical capacity,suitable operation voltage and abundant resource.Unfortunately,the application of NiP_(2) anode is severely impeded by low practical capacity and fast capacity decay due to the huge volume variation and low reactivity of internal phosphorus(P)component towards Na^(+).Herein,electronic structure modulation of NiP_(2) via heteroatoms doping and introducing vacancies defects to enhance Na+adsorption sites and diffusion kinetics is successfully attempted.The as-synthesized three-dimensional(3D)bicontinuous carbon matrix decorated with well-dispersed fluorine(F)-doped NiP_(2) nanoparticles(F-NiP_(2)@carbon nanosheets)delivers a high reversible capacity(585 mAh·g^(−1) at 0.1 A·g^(−1))and excellent long cycling stability(244 mAh·g^(−1) over 1,000 cycles at 2 A·g^(−1))when tested as anode in NIBs.Density functional theory(DFT)calculations reveal that F doping in NiP_(2) induces the formation of P vacancies with increased Na+adsorption energy and accelerates the alloying of internal P component.The F-NiP_(2)@carbon nanosheets//Na_(3)V_(2)(PO_(4))_(3) full cell is evaluated showing stable long cycling life.The heteroatoms doping-induced dual defects strategy opens up a new way of metal phosphides for sodium storage. 展开更多
关键词 NiP_(2) electronic structure modulation f doping P vacancies dual defects sodium-ion batteries
原文传递
食管癌容积旋转调强与动态调强放疗计划的等效生物剂量分布比较 被引量:10
5
作者 陈翠 张广顺 +1 位作者 卢丽霞 邓小武 《中华肿瘤防治杂志》 CAS 北大核心 2018年第15期1075-1080,共6页
目的食管癌使用不同调强放射治疗技术会得到不同物理剂量和等效生物剂量分布。使用等效生物剂量评估可以更好预测放疗效果。本研究比较使用容积旋转调强(volumetric modulated arc therapy,VMAT)和5野、7野、9野动态调强(5F-,7F-,9F-dyn... 目的食管癌使用不同调强放射治疗技术会得到不同物理剂量和等效生物剂量分布。使用等效生物剂量评估可以更好预测放疗效果。本研究比较使用容积旋转调强(volumetric modulated arc therapy,VMAT)和5野、7野、9野动态调强(5F-,7F-,9F-dynamic MLC-IMRT)4种技术在食管癌放疗计划中的等效生物剂量(equivalent dose in 2Gy/f,EQD2)与物理剂量的分布差别,为临床选择最佳放疗技术提供依据。方法选择中山大学肿瘤防治中心2015-03-05-2015-06-27收治的20例食管癌患者,分别使用5F-、7F-、9F-dMLC-IMRT和VMAT技术各设计4套计划,所有计划使用相同的临床目标和剂量限制条件,肿瘤靶区的处方剂量均为60Gy/28f。根据各器官的α/β值和线性二次(linearquadratic,L-Q)模型,采用自编软件对治疗计划所有体素点物理剂量进行转换,得到治疗计划各体素点的EQD2剂量、以及靶区和危及器官的生物等效剂量体积(DVHEQD2)数据。比较不同调强放疗技术物理剂量和生物等效剂量体积参数差异,包括靶区相关剂量参数、适形指数(conformal index,CI)、均匀性指数(homogeneity index,HI)和脊髓、肺、心脏等危及器官体积剂量参数,并根据EQD2剂量分布综合结果选择最佳放疗技术。结果肿瘤区和预防照射区剂量体积参数中生物等效剂量(DEQD2)与物理剂量(DPhys)差别<3.5%;各危及器官的剂量参数中,DEQD2低于DPhys,均>10%。使用DEQD2对4种调强放疗技术进行比较,肿瘤区的处方剂量包绕体积均>98%,差别没有统计学意义(P>0.05),VMAT的靶区适形性(适形指数CI=0.554)高于动态调强技术技术(适形指数CI9F、CI7F和CI5F分别为0.535、0.473和0.408),P<0.001;危及器官的剂量参数中,脊髓最大量、心脏的平均剂量、肺的平均剂量和体积剂量VEQD2-20Gy和VEQD2-30Gy在不同调强技术之间差异<3%。VMAT技术肺的VEQD2-5Gy比5F-IMRT高4.51%,低于使用物理剂量评估时的7.58%。结论综合比较4组不同调强计划的剂量体积参数,食管癌调强放疗使用VMAT技术在EQD2的分布上比其他3种技术更有优势。 展开更多
关键词 食管癌 调强放射治疗 等效生物剂量 线性二次模型
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部